CSS
ATOS icon

Cubist Systematic Strategies’s Atossa Therapeutics ATOS Stock Holding History

Cubist Systematic Strategies’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-741
Closed -$9.22K – 3043
2025
Q2 		$9.22K Buy
+741
New +$8.86K ﹤0.01% 2841
2022
Q3 		– Sell
-1,347
Closed -$22K – 4412
2022
Q2 		$22K Buy
+1,347
New +$21.2K ﹤0.01% 4203
2021
Q4 		– Sell
-1,191
Closed -$58K – 3453
2021
Q3 		$58K Buy
1,191
+841
+240% +$48.9K ﹤0.01% 2822
2021
Q2 		$33K Buy
+350
New +$18.5K ﹤0.01% 2821

Other funds holding ATOS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $431B AUM 30.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return